Impacts of lncRNA AFAP1-AS1 silencing on LC phenotypes were tested in vitro via CCK-8, clone formation, EdU staining, wound healing, flow cytometry, and Transwell assay. The gene discussed is AFAP1; the disease is laryngotracheoesophageal cleft.